Methyl 5-bromo-2-methoxy-3-methylbenzenecarboxylate, 97%, 250mg

(4-Chloro-3-(pyrrolidine-1-carbonyl)phenyl)boronic acid, 95.0%, 100mg

Denatured ethanol, min. 99.8%, pa, denatured, 5 l, plastic packaging.

4-METHOXY-PIPERIDINE-4-CARBOXYLIC ACID HCL, 95.0%, 100mg

2,4-Dichlorobenzyl isothiocyanate, 99.0%, 2g

3-(4-methylpiperidin-1-yl)propan-1-ol, 95.0%, 1g

N-(tert-Butoxycarbonyl)-L-methionine>98.0%(HPLC)(T)10g

5-Bromo-2-fluoro-N,N-dimethylnicotinamide, 97%, 1g

Methyl 3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95%, 100mg

1-(3-amino-4-methylphenyl)-9-(furan-3-yl)benzo[h][1,6]naphthyridin-2(1H)-one, 97%, 100mg

5-biphenyl-4-ylisoxazole-3-carboxylic acid, 95.0%, 1g

Lithium hydroxide, min. 99%, anhydrous, 25 g, plastic packaging.

(4R)-4-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-1-METHYL-D-PROLINE, 95.0%, 250mg